-
Transformative Treatments for
Inflammatory DisordersResolvin-based Therapies for Inflammation Resolution and Tissue Repair
Resolvins: A Transformative New Class of Immunoregulatory Drugs
Discovered by biomedical researchers at Harvard Medical School, Resolvins are a novel class of immunoregulatory autacoids that resolve inflammation and promote tissue repair.
Our Technology
Our HEALER technology enables the pharmaceutical development of Resolvins and other bioactive lipids as new molecules with enhanced stability, bioavailability, formulation properties, and patent protection.
Resolvins
Novel agonists of inflammation resolution and tissue repair
HEALER™ Platform
Enabling the development of Resolvins as pharmaceutical drugs
Intellectual Property
Long-term composition of matter patent protection
"We are committed to creating innovative products that improve
the lives of patients suffering from autoimmune and inflammatory diseases."
- Frank C. Sciavolino, Ph.D., Founder and Chief Scientific Officer